过去 90 天内没有内部人买入。最近一笔由 QUANTITATIS (ANCIEN) SARL 披露于 2025年12月26日。
Plant Advanced Technologies PAT：高管交易动态
以下是Plant Advanced Technologies PAT高管的股票交易情况，数据经由AMF发布；该公司属于医疗与制药行业。2025年11月7日至2026年11月7日期间，4位高管共发布了43份申报。
公开市场交易分为17笔买入，合计€1,862和26笔卖出，合计€8.8万；买方共4位高管，卖方共3位高管。以净额计，卖出占上风，差额为€8.6万。公开市场买入是最受关注的申报类型，因为高管是用自己的钱购买股份。买入者中有3位首席执行官和1位董事。2025年12月18日由Quantitatis Sarl公布的卖出金额为€9,363，是期内最大的一笔。
有记录的最近一笔买入公布于2025年12月26日，即317天前。一般而言，一笔交易从发生到公布的中位间隔为50天。作为对比，欧盟《市场滥用条例》（MAR）第19条给予高管三个工作日申报交易。卖出比买入更难解读，因为卖出往往出于纳税、理财等个人需要。
与所在交易所相比（314家公司，中位数7份申报），43份申报的数量高于常态。完整历史始于2021年，共计22笔买入、34笔卖出。
在同一行业，Dynavox Group AB和Vetoquinol SA近期的高管买入同样出现在我们的信号中。以上数据均来自AMF发布的申报，描述的是过去的情况，不代表未来股价走势，也不构成投资建议。
谁在何时交易
买入卖出内部人买入以来
- -52.5%入场价 €8.42 · 2026年11月06日 收盘 €4.00
- -52.4%入场价 €8.40 · 2026年11月06日 收盘 €4.00
- -23.8%入场价 €22.30 · T+365 收盘 €17.00
入场价为披露次日收盘价，即读者可操作的第一个价格。价格以上市货币计。过往涨跌不代表未来表现。
透明的价值 + 质量排名，独立于内部人交易信号。
财务数据
财年 2024财年截至 2024年12月 · cache
- 550 股@ €8.081823.6% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1086337
- 35 股@ €8.3714股票Euronext Growth ParisISIN FR00107857902025DD1086337-T2标准退出：2026年3月23日 (T+90)
- 726 股@ €8.143831.4% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1085743
- 23 股@ €8.52351.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1085743-T2标准退出：2026年3月19日 (T+90)
- 1,140 股@ €8.2131100.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1075204
- 115 股@ €8.149.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1075204-T3
- 25 股@ €8.316股票Euronext Growth ParisISIN FR00107857902025DD1075204-T2标准退出：2026年3月15日 (T+90)
- 10 股@ €8.540.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1075208标准退出：2026年3月15日 (T+90)
- 10 股@ €8.400.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1075208-T2标准退出：2026年3月16日 (T+90)
- 276 股@ €8.655.2% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068555
- 342 股@ €8.556.4% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068556
- 218 股@ €8.414.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068558
- 774 股@ €8.3014.0% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068561
- 171 股@ €8.6943.2% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068490
- 272 股@ €8.62495.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068498
- 131 股@ €8.71561.3% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068498-T2
- 305 股@ €8.61123.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068498-T3
- 504 股@ €8.80165.2% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068498-T4
- 74 股@ €8.821.4% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534
- 6 股@ €9.080.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T9标准退出：2025年12月23日 (T+90)
- 9 股@ €9.04670.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T10标准退出：2025年12月22日 (T+90)
- 723 股@ €8.84259.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T2
- 671 股@ €8.82638.4% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T3
- 359 股@ €9.004.6% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T4
- 4 股@ €8.900.1% 占其流量股票Euronext Growth ParisISIN FR00107857902025DD1068534-T7标准退出：2025年12月25日 (T+90)
56 条申报中的 25 条
About Plant Advanced Technologies PAT
Plant Advanced Technologies PAT is a French plant-biotechnology company listed on Euronext Growth Paris under ISIN FR0010785790 (ticker ALPAT). Founded in June 2005 in Nancy, the company was originally created to develop and industrialize the PAT plantes à traire® technology, which was built on research from the Institut National Polytechnique de Lorraine and INRA. Since then, PAT has established itself in a highly specialized niche focused on the discovery, optimization and industrial production of rare plant biomolecules that have traditionally been difficult to source at scale.
PAT’s core business is the development of plant-derived active ingredients for the cosmetics, pharmaceutical and agrochemical industries, with an expanding presence in nutraceuticals and fine chemicals. The group emphasizes exclusive, high-value solutions that combine innovation, traceability and control over the full value chain, from the plant to the final product. Its technological platform includes proprietary approaches such as PAT plantes à traire® and PAT Friday®, as well as metabolic engineering and microbial fermentation through its Cellengo subsidiary.
展开全文收起
Over time, PAT has built a diversified scientific and industrial platform. In cosmetics, it regularly launches new active ingredients and works with industrial partners. In pharmaceuticals, its Temisis subsidiary is focused on small molecules with notable anti-inflammatory potential. In agrochemistry, PAT develops and tests molecules for crop protection. The group also owns StratiCell, which provides cosmetic efficacy and safety testing, and Couleurs de Plantes, which specializes in plant-based colorants. These assets broaden PAT’s commercial reach while leveraging the same underlying scientific expertise.
From a market positioning standpoint, PAT is best described as an innovation-driven niche specialist rather than a large-scale industrial supplier. Its competitive strength lies in scarce active ingredients, a sizeable intellectual-property portfolio, and a strong scientific workforce of more than 60 employees, roughly two-thirds of whom are dedicated to R&D. The company also highlights its sustainability credentials, including a 2024 EcoVadis Gold medal.
Financially, PAT reached an important milestone in 2024 by posting its first operating profit since inception, at €215k, on revenue of €1.927 million. In the first half of 2025, revenue stood at €155k in a seasonal business context, while debt continued to decline and management reiterated its goal of generating a third consecutive full-year profit. Headquartered in Vandœuvre-lès-Nancy, the group maintains an operational and partnership footprint in France and Belgium, while targeting international markets through collaborations and patented technologies.
同行业近期入选信号
我们的模型当前为推荐列表排序的买入。
全部推荐
